aquestive.com - AQST Company profit before taxes, interest and amortization
Aquestive Therapeutics (AQST) is implementing innovative PharmFilm oral films for the treatment of epilepsy and allergies. The organization's overall EBITDA demonstrates profit dynamics, where the value of 0.00 serves as the current metric. The company relies moderately on external partners for research while maintaining control over synthesis. Stable pipeline utilization and the modernization of cleanrooms ensure a steady increase in production volumes.
Aquestive Therapeutics, Inc. (AQST) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Aquestive Therapeutics|AQST - Long-Term Debt to Capital|Short-Term Debt to Capital Aquestive Therapeutics Inc|AQST - Company Debts|Debt to Net Assets Aquestive Therapeutics|AQST - Company Long-Term Liabilities|Company Short-Term Debts Aquestive Therapeutics|Immediate Liquidity aquestive.com
- earnings and market ratios statistics:
AQST - Company Net Income|Company Profit Forecast Aquestive Therapeutics|AQST - Price to Earnings Ratio|Market Cap to Future Earnings Ratio aquestive.com|AQST - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aquestive Therapeutics|AQST - Operating profit before deduction of amortization|Earnings per share for the last twelve months Aquestive Therapeutics|AQST - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months aquestive.com|AQST - Net earnings per share growth this year|Expected earnings per share trend next year Aquestive Therapeutics
Analysis of all company metrics:AQST, Aquestive Corp
A conservative investor evaluates asset value through a business's ability to generate sustainable cash flow. This indicator captures net operating income before depreciation, reflecting the real efficiency of core operations. By analyzing operating earnings trends, one can identify scaling cycles for the PharmFilm technology. The rapid adaptation of drugs into film format should convert into profit growth. This positive trend confirms the commercial success of the Aquestive Therapeutics (AQST) engineering platform.
Competitor analysis for Aquestive Therapeutics
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|Operating profit EBITDA ANI Pharmaceuticals Inc ANIP|MNKD - Profit before payment of interest, taxes and amortization|Operating profit before depreciation charges Amphastar Corp (AMPH)|PCRX (Pacira BioSciences) - Operating profit before deduction of amortization|ars-pharma.com (SPRY) - Operating profit EBITDA|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization scPharma SCPH|Profit before payment of interest, taxes and amortization Tectonic Therapeutic, Inc. (TECX)|Operating income before deduction of amortization Tonix Pharmaceuticals Holding|China SXT Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization EPRX (Eupraxia Pharmaceuticals, Inc.)|BioHarvest Sciences Inc. - Operating profit EBITDA|Operating income before deduction of amortization Invizyne Technologies EXOZ|ORMP (oramed.com) - Operating profit before deduction of amortization|ENTX (Entera Bio) - Profit before payment of interest, taxes and amortization|HYFT (MindWalk Holdings) - Operating profit EBITDA|Profit before interest, taxes and amortization abvcpharma.com ABVC|Operating profit before deduction of amortization CPIX (Cumberland Pharmaceuticals Inc.)|QNTM (Quantum BioPharma Ltd.) - Income before deduction of interest, taxes and amortization|FibroGen Corp - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TELO (Telomir Pharmaceuticals Corp)|Rani Therapeutics Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization SNYR (Synergy CHC Corp)|RLYB: Operating profit EBITDA|Profit before interest, taxes and amortization Lexaria Bioscience Corp. (LEXX)|Profit before payment of interest, taxes and amortization Pulmatrix Corp|PTHL: Income before deduction of interest, taxes and amortization|Operating profit EBITDA APM|Operating profit EBITDA lyratherapeutics.com (LYRA)|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|TNFA (TNF Pharmaceuticals Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|cbdMD Corp - Operating profit EBITDA|Profit before interest, taxes and amortization PainReform Corp|CYTO (altamiratherapeutics.com) - Operating profit before deduction of amortization|lipella.com (LIPO) - Operating profit EBITDA|Operating profit before deduction of amortization OPTN|PIRS (Pieris Pharmaceuticals Inc) - Company profit before taxes, interest and amortization|Operating profit EBITDA PROC|Operating income before deduction of amortization Petros Pharma|Operating profit EBITDA QLI (Qilian International)|SLRN - Operating profit before deduction of amortization|TFFP - Profit before payment of interest, taxes and amortization
